CT-guided ozone mixture injection in treatment of symptomatic lumbar facet synovial cysts.
Journal
Acta bio-medica : Atenei Parmensis
ISSN: 2531-6745
Titre abrégé: Acta Biomed
Pays: Italy
ID NLM: 101295064
Informations de publication
Date de publication:
13 02 2023
13 02 2023
Historique:
received:
03
03
2022
accepted:
08
09
2022
entrez:
14
2
2023
pubmed:
15
2
2023
medline:
16
2
2023
Statut:
epublish
Résumé
To evaluate the clinical and radiological outcomes, in terms of safety and efficacy, of a new treatment method for symptomatic lumbar facet synovial cysts (LFSC), based on ozone injection inside the cyst. We retrospectively reviewed clinical records and imaging studies of 77 patients who underwent CT-guided ozone treatment of symptomatic facet joint synovial cysts in our department over a 5-year span. Clinical outcome was assessed with Numerical Rating Scale (NRS) and Oswestry Disability Index (ODI) evaluations, obtained prior to the intervention and at 1-, 3-, 6- and 12-months follow-up. Follow-up MRI imaging at 6 and 12 months were obtained and confronted with the pre-procedural MRI to analyse cyst modification after the intervention. Ozone administration was technically successful in 100% of procedures; no immediate complications occurred. At 1 month evaluation, 92% of the patients referred partial or complete symptomatic response; 86% of patients at 3 months and 84% at 6 months confirmed symptoms improvement; final assessment, at 12 months after intervention, outlined overall significant clinical improvement in 81% of patients. During the 12 months of follow-up only 3 patients had a relapse of the cyst (at 6 months) that were retreated with a 100% success. CT-guided ozone therapy for symptomatic LFSC is a safe and innovative treatment option, with good clinical results at 12 months follow-up in a significative percentage of patients, thus reducing the need for invasive surgical interventions.
Sections du résumé
BACKGROUND AND AIM
To evaluate the clinical and radiological outcomes, in terms of safety and efficacy, of a new treatment method for symptomatic lumbar facet synovial cysts (LFSC), based on ozone injection inside the cyst.
METHODS
We retrospectively reviewed clinical records and imaging studies of 77 patients who underwent CT-guided ozone treatment of symptomatic facet joint synovial cysts in our department over a 5-year span. Clinical outcome was assessed with Numerical Rating Scale (NRS) and Oswestry Disability Index (ODI) evaluations, obtained prior to the intervention and at 1-, 3-, 6- and 12-months follow-up. Follow-up MRI imaging at 6 and 12 months were obtained and confronted with the pre-procedural MRI to analyse cyst modification after the intervention.
RESULTS
Ozone administration was technically successful in 100% of procedures; no immediate complications occurred. At 1 month evaluation, 92% of the patients referred partial or complete symptomatic response; 86% of patients at 3 months and 84% at 6 months confirmed symptoms improvement; final assessment, at 12 months after intervention, outlined overall significant clinical improvement in 81% of patients. During the 12 months of follow-up only 3 patients had a relapse of the cyst (at 6 months) that were retreated with a 100% success.
CONCLUSIONS
CT-guided ozone therapy for symptomatic LFSC is a safe and innovative treatment option, with good clinical results at 12 months follow-up in a significative percentage of patients, thus reducing the need for invasive surgical interventions.
Identifiants
pubmed: 36786272
doi: 10.23750/abm.v94i1.12991
pmc: PMC9987492
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2023025Références
AJNR Am J Neuroradiol. 2003 May;24(5):996-1000
pubmed: 12748111
Acta Clin Croat. 2019 Sep;58(3):491-496
pubmed: 31969762
Pain Physician. 2012 Sep-Oct;15(5):435-40
pubmed: 22996855
Pain Physician. 2012 Mar-Apr;15(2):E115-29
pubmed: 22430658
J Clin Neurosci. 2019 Apr;62:112-116
pubmed: 30580916
Neurol Med Chir (Tokyo). 2008 Jul;48(7):298-303; discussion 303
pubmed: 18654048
Int J Spine Surg. 2022 Jul 14;:
pubmed: 35835576
BMC Surg. 2022 Jul 15;22(1):277
pubmed: 35841087
Turk Neurosurg. 2021;31(5):718-724
pubmed: 34169988
Am J Transl Res. 2019 May 15;11(5):3109-3115
pubmed: 31217880
Clin Spine Surg. 2018 Jun;31(5):E296-E301
pubmed: 29727308
Ann N Y Acad Sci. 1988;551:128-30
pubmed: 3245656
Eur Radiol. 2012 Dec;22(12):2836-40
pubmed: 22688130
Lymphokine Cytokine Res. 1993 Apr;12(2):121-6
pubmed: 8324077
Spine J. 2009 Nov;9(11):899-904
pubmed: 19664971
Radiology. 2006 Nov;241(2):618-21
pubmed: 17057079
Radiology. 1999 Feb;210(2):509-13
pubmed: 10207437
J Vasc Interv Radiol. 2017 Aug;28(8):1083-1089
pubmed: 28549711
Br J Biomed Sci. 1999;56(4):270-9
pubmed: 10795372
Surg Neurol Int. 2012;3(Suppl 3):S157-66
pubmed: 22905322
AJNR Am J Neuroradiol. 2018 Jan;39(1):193-198
pubmed: 29122762
Spine J. 2009 May;9(5):387-95
pubmed: 18809358
Histopathology. 2018 May;72(6):923-929
pubmed: 29314220
Eur Spine J. 2006 Aug;15(8):1176-82
pubmed: 16440202
Surg Neurol. 1995 May;43(5):459-64; discussion 465
pubmed: 7660284
Pain Physician. 2016 Sep-Oct;19(7):E1019-25
pubmed: 27676672
Eur Spine J. 2008 Jun;17(6):831-7
pubmed: 18389295